Sequoia Capital China completed almost $15 million Series B investment in Beijing-based Deep Intelligent Pharma (DIP), a Chinese startup that provides artificial intelligence (AI) technology for drug development, on September 28, though it was not announced until October 9.
¬ Haymarket Media Limited. All rights reserved.
